Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Acquires Cell-Based Screening Technology from Amphora

NEW YORK, May 6 (GenomeWeb News) - Caliper Life Sciences, of Hopkinton, Mass., will acquire technology developed for cell-based screening assays by Amphora, of Research Triangle Park, N.C., the companies said today. Caliper will use the technology to develop a new calcium-flux assay for G-protein-coupled receptor drug targets.


Amphora will transfer to Caliper its proprietary cell culture techniques, as well as hardware and software upgrades that Amphora has integrated into Caliper's microfluidic screening system. In exchange, Caliper will compensate Amphora with cash, products, and royalties based on future sales of cell-based assays, the companies said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.